Trial intelligence / Profile preview

Tang-min-ling Pills in Type 2 Diabetes

NCT01107171Phase 2Completed

Sponsor
Guang'anmen Hospital
Start
May 2008
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of tangminling in type 2 diabetes mellitus (T2DM), sponsored by Guang'anmen Hospital. Started May 2008; status: completed.

02

Drugs

tangminling
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01107171.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01107171.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call